With more than 85 years of experience and offering full service to support projects from proof of concept to commercial manufacture, Uquifa’s business model is based on a combination of  quality manufacturing platform and a great track record of service and reliability. UQUIFA Group is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and animal health industries globally.

The UQUIFA Group has 2 manufacturing sites (1 in Spain and 1 in Mexico), operating under Uquifa Brand, with strict adherence to all regulatory norms. These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA.

Soneas Chemicals Ltd, a Budapest-based company focused on CDMO activities, is also a part of the UQUIFA Group since 2018. Soneas Chemicals Ltd. offers route scouting, process optimisation, small scale cGMP manufacturing, and large scale non-GMP manufacturing from 3 locations in Budapest.

UQUIFA Group has clients in over 70 countries worldwide. Working in Phase I, II or III projects with Innovative Companies having more than 150 active DMF’s filed and more than 25 CEP’s approved. Uquifa counts the major global generic and ethical companies amongst its customers. R&D and innovation remains at the core of the Company’s strategy. It continues to make balanced investment in People, Products, and Plants to stay ahead of the technological curve.